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Progressive high-load strength training compared
with general low-load exercises in patients with
rotator cuff tendinopathy: study protocol for a
randomised controlled trial
Kim G Ingwersen1,2*, Robin Christensen3, Lilli Sørensen4, Hans RI Jørgensen5, Steen Lund Jensen6,
Sten Rasmussen7,8, Karen Søgaard1 and Birgit Juul-Kristensen1,9
Abstract
Background: Shoulder pain is the third most common musculoskeletal disorder, often affecting people’s daily
living and work capacity. The most common shoulder disorder is the subacromial impingement syndrome (SIS)
which, among other pathophysiological changes, is often characterised by rotator cuff tendinopathy. Exercise is
often considered the primary treatment option for rotator cuff tendinopathy, but there is no consensus on which
exercise strategy is the most effective. As eccentric and high-load strength training have been shown to have a
positive effect on patella and Achilles tendinopathy, the aim of this trial is to compare the efficacy of progressive
high-load exercises with traditional low-load exercises in patients with rotator cuff tendinopathy.
Methods/Design: The current study is a randomised, participant- and assessor-blinded, controlled multicentre trial.
A total of 260 patients with rotator cuff tendinopathy will be recruited from three outpatient shoulder departments
in Denmark, and randomised to either 12 weeks of progressive high-load strength training or to general low-load
exercises. Patients will receive six individually guided exercise sessions with a physiotherapist and perform home-based
exercises three times a week. The primary outcome measure will be change from baseline to 12 weeks in the
patient-reported outcome Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.
Discussion: Previous studies of exercise treatment for SIS have not differentiated between subgroups of SIS and have
often had methodological flaws, making it difficult to specifically design target treatment for patients diagnosed with
SIS. Therefore, it was considered important to focus on a subgroup such as tendinopathy, with a specific tailored
intervention strategy based on evidence from other regions of the body, and to clearly describe the intervention in a
methodologically strong study.
Trial registration: The trial was registered with Clinicaltrials.gov (NCT01984203) on 31 October 2013.
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Background
People with pain in the neck and shoulder region are
often disabled to the point where they cannot live a nor-
mal life. The pain may also influence the person’s work
capacity and financial as well as social situation. Pain in
the shoulder is the third most common musculoskeletal
disorder, and the lifetime prevalence is estimated to be
between seven and 10% [1]. The prevalence for daily
non-specific shoulder pain in a normal working popula-
tion in an industrialised country is estimated to be 12%
[2]. Furthermore, up to 23% of the workforce seeking
care from the healthcare system with a shoulder prob-
lem have been sick-listed for more than one week [3].
Clinically, the most common shoulder-related cause of
contact with the healthcare system is subacromial im-
pingement syndrome (SIS), which accounts for 33% of
all shoulder-related healthcare contact [4,5]. SIS is gene-
rally considered to be a cluster of symptoms, rather than
a single pathology. The Complaints of the Arm, Neck
and/or Shoulder (CANS) model defines SIS as ‘Disorders
that include the rotator cuff syndrome, tendonitis of the
m. infraspinatus, m. supraspinatus and m. subscapularis,
and bursitis in the shoulder area’ [6]. The cause of SIS is
considered to be multi-factorial and involves an altered
muscle recruitment pattern in the rotator cuff and thor-
acoscapular muscles, potentially in combination with al-
terations to the anatomical structures in the subacromial
space. These alterations may result in varying degrees of
micro-traumas and degenerative pathophysiological
changes in the rotator cuff muscle and surrounding tissue,
which eventually can result in rotator cuff tendinopathy.
Generally, the clinically relevant pathophysiological con-
ditions associated with the diagnosis of SIS, such as
rotator cuff tendinopathy, are often difficult to identify
objectively [7,8], and consequently the diagnosis of
rotator cuff tendinopathy is primarily based on a com-
bination of the patient’s history, clinical tests and ultra-
sonographic visualisation of changes in the rotator cuff
tendons.
The Danish national clinical guidelines for the treat-
ment of SIS recommend active rehabilitation strategies,
and in cases where three to six months of exercise has
been ineffective, arthroscopic subacromial decompres-
sion surgery can be considered [9]. These recommenda-
tions are, amongst others, based on the evidence that
exercise has shown results comparable to arthroscopic
subacromial decompression when evaluated on pain and
patient-reported function [10-14]. However, the recom-
mended guidelines rarely describe specific exercise pro-
grammes, nor are they sufficient in detail to be targeted
at subgroups of SIS, such as rotator cuff tendinopathy.
This means there is no consensus on specific rehabilita-
tion exercise programmes for SIS patients with rotator
cuff tendinopathy.
Among patients with Achilles or patella tendinopathy,
studies of eccentric or progressive high-load exercises
have shown promising effects on pain and function [15],
and such exercises for chronic tendinopathy are often
considered to be the first line of treatment [16-18]. Some
of the mechanisms believed to be responsible for the posi-
tive outcomes of eccentric exercises are reduced structural
abnormalities, such as hypoechoic areas, irregular struc-
tures, neovascularisation and tendon thickness [19,20].
The reasons for these changes could possibly be increased
collagen type I synthesis [21]. Considering that collagen
synthesis peaks at between 24 and 72 hours post-exercise
[22], programmes prescribing daily training, such as those
recommended for standard eccentric exercise programs,
might not be optimal [23]. In support of this, very high-
load eccentric training with relatively few repetitions and
low frequency (twice a week) has shown equally beneficial
effects on patella tendinopathy [24,25]. Also, concentric
heavy slow resistance exercises, without emphasis on the
eccentric component, three times a week [25] has shown
positive effects on patella tendinopathy. Furthermore,
heavy slow resistance exercises seem to reduce abnormal
fibrillar morphology among patients with patella tendino-
pathy [26].
However, rotator cuff tendinopathy is often treated as
any other subgroup of SIS, with a combination of low-
load exercises for internal and external rotation of the
shoulder joint, with an attempt to target the rotator cuff
muscles and optimise muscle coordination. Only a few
studies have used progressive exercises or eccentric exer-
cises in patients with SIS, and they have reported posi-
tive results on pain and function [27-32]. But all these
studies have primarily targeted SIS and did not diffe-
rentiate between the underlying pathologies. Inclusion of
different subgroups of SIS in the same trial makes it dif-
ficult to customise an optimal exercise programme and,
possibly, to detect a clinically relevant change between
different exercise strategies [8].
Based on the evidence reported from studies on knee,
Achilles and elbow tendons, applying eccentric or high-
load exercise programmes in patients with rotator cuff
tendinopathy could be beneficial for patients’ pain, func-
tion and quality of life [8], and for ultrasonographic
visualised structural changes [33-35], when compared
with traditional exercise strategies. But the rationale for
using progressive high-load exercises is the diagnosis of
tendinopathy and therefore, unlike existing studies, a
study of eccentric or progressive high-load exercises
should include only patients with tendinopathy. To our
knowledge, no studies have investigated the effect on
pain and function of progressive high-load exercises
compared with traditional low-load exercises in the sub-
group of SIS patients primarily showing signs of rotator
cuff tendinopathy. A proportion of patients diagnosed
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with tendinopathy will also have a concomitant path-
ology in the surrounding tissue of the glenohumeral
joint. Often corticosteroid injection into the subacromial
space is used as an adjunct treatment for exercise inter-
ventions, if regarded relevant by the orthopaedic specia-
list. It is uncertain if this concomitant treatment has an
additional effect on the exercise treatment.
The aim of the study is to determine in a randomised,
double-blind controlled trial if a progressive high-load
exercise programme for the rotator cuff muscles is
superior to a traditional low-load exercise programme in
patients with rotator cuff tendinopathy, based on the
primary endpoint; change in score on the Disabilities of
the Arm, Shoulder and Hand (DASH) questionnaire [36]
after 12 weeks of exercise. The second aim is to evaluate
the possible interaction of concomitant use of corticoste-
roids with the exercise intervention.
Methods/Design
Study design
This trial, called the Rotator Cuff Tendinopathy Exercise
(RoCTEx) trial, is a multicentre (three sites), stratified (by
corticosteroid injection (yes or no)), randomised, con-
trolled, observer- and patient-blinded superiority trial,
with a two-group parallel design, to be conducted in
Denmark. The primary endpoint will be 12 weeks after
baseline. Patients will be randomised to either progressive
high-load exercises or low-load exercises (block rando-
misation with a 1:1 allocation). As illustrated in Figure 1,
patients will also be assessed at one year from the baseline,
referred to as the follow-up assessment.
Settings and locations
Patients will be recruited from the shoulder units at
the outpatient clinics of orthopaedic departments at the
Hospital Lillebaelt - Vejle Hospital, Aalborg University
Hospital - Farsø Hospital and Odense University Hospital -
Svendborg Hospital.
Participants
The orthopaedic specialists will perform a standardized
initial screening of all patients referred to the shoulder
units. If patients fulfil the eligibility criteria they will be
referred to the principal investigator, who will perform
the final eligibility assessment and give detailed infor-
mation about the study. Patients will be invited to par-
ticipate if they meet the following inclusion criteria:
between 18 and 65 years of age, have a current shoulder
complaint lasting at least three months prior to the time
of enrolment, pain is located in the proximal lateral
aspect of the upper arm (C5 dermatome) that is ag-
gravated by abduction, a positive ‘Full Can Test’ and/or
Jobe’s test and/or Resisted External Rotation Test, a positive
Hawkins-Kennedy test and/or Neer’s test, ultrasonographic
verification of either tendon swelling, and/or presence of
hypoechoic areas, calcification, fibrillar disruption and/or
neovascularisation in the m. supraspinatus.
Patients will be excluded if they fulfil any of the fol-
lowing exclusion criteria: Resting pain more than 40 mm
on a visual analogue pain scale (range: 0 to 100), bilateral
shoulder pain, less than 90 degrees of active elevation of
the arm, a full thickness rupture in the rotator cuff ten-
don verified by ultrasonography, presence of calcification
larger than 5 mm (vertical distance) verified by x-ray,
corticosteroid injection within the last six weeks, a ra-
diologically verified fracture, glenohumeral osteoarthritis,
prior surgery or dislocation of the affected shoulder, a
clinically suspected labrum lesion, symptomatic arthritis
in the acromioclavicular joint, a frozen shoulder or symp-
toms derived from the cervical spine, sensory or motor
deficit in the neck or arm, suspected competing diagnoses
(for example, rheumatoid arthritis, cancer, neurological
disorders, fibromyalgia, psychiatric illness), pregnancy or
inability to understand spoken and written Danish.
Interventions
Generally, both groups will receive the same exercises
(although they differ on the amount of load), attention
and basic information about ergonomic corrections re-
lated to the daily use of the upper extremity. The exer-
cise program will consist of six exercises: two exercises
for the scapula stabilising muscles (push-up plus exercise
and low row exercise), two for the rotator cuff muscles
(scaption and side-lying external rotation), and two
stretching and mobility exercises (posterior capsule stretch
and scapulae retraction). Patients will be instructed in per-
forming home-based training three times per week, and
will be seen for initial instruction in week one (60 minutes),
and follow-up exercise sessions (30 minutes) in weeks
two, three, four, six and nine. The general information
about the project and exercise instructions will be given
through a DVD to minimise the influence of the physio-
therapist. On the first visit to the physiotherapist, the pa-
tients will receive detailed instructions on how to perform
the exercise programme based on the instructions on the
DVD. At the follow-up exercise sessions corrections will
be made, and weights adjusted. The patients will be given
a copy of the DVD and an exercise brochure to enable
them to follow the instructions and exercises at home.
The difference between the intervention and control
groups will be the external load targeting exercises for
the rotator cuff. The intervention group will perform
12 weeks of progressive high-load exercises, gradually
increasing the load from 15 repetitions maximum (RM)
in week one to six RM in weeks nine to 12. The inter-
vention group will only be allowed to do isometric exer-
cises if the pain exceeds 50 mm on the visual analogue
scale. The control group will perform 12 weeks of low-
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load exercises, performed with 20 RM from weeks one
to 12. For both groups, scapulae exercises will be per-
formed with 20 RM, and stretching and mobility exer-
cises will be performed five times, for 20 seconds each,
in weeks one to 12.
Concomitant use of corticosteroid injections will be
based on the orthopaedic specialist’s evaluation, in ac-
cordance with the department’s standard procedures.
Between 25 and 50% of patients are expected to receive
injections. The corticosteroid injections will be given to
patients at the shoulder unit of the orthopaedic depart-
ments, after baseline assessment but before randomisa-
tion. Randomisation will be performed in a stratified
manner to ensure even distribution of patients receiving
and not receiving corticosteroid injections in the two
exercise groups.
Outcome measures
The primary outcome measure will be change from
baseline to week 12 in the patient-reported outcome
Disabilities of the Arm, Shoulder and Hand (DASH)
questionnaire (0 to 100 score, 100 = no problems) [36],
and reported as the difference in mean change between
the groups. The secondary endpoint assessment on the
primary outcome will be performed 12 months after
baseline (Figure 1).
The secondary outcome, measured at baseline and after
12 weeks, will include: the Shoulder injury and Osteo-
arthritis Outcome Score (SOOS; 0 to 100 score, 100 = no
problems) [37], the Hospital Anxiety and Depression Scale
(HAD Scale; 0 to 21 score, 0 = no problems) [38], EuroQol
instrument (EQ-5D index; −0.59 to 1 score, −0.59 = lowest
health-related quality of life), EuroQol Visual Analogue
Figure 1 Expected flow of participants through the study. LLE: low-load exercises; PHLE: Progressive high-load exercises.
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Scale (EQ-VAS; 0 to 100 score, 0 = lowest health-related
quality of life) [39], perceived pain at rest, general activity
and maximum pain experienced during the previous
24 hours (visual analogue scale, 0 to 100 score, 0 = no
pain) [40], maximum isometric voluntary contraction
(MVC) of external and/or internal rotation and scaption
measured by dynamometers, active and passive range of
movement in scaption (0 to 180 degrees), external (0 to 90
degrees) and internal rotation (0 to 90 degrees) measured
by goniometer, clinical tests (Scapula Assistance Test [41],
Scapula Retraction Test (positive or negative) [42] and
ultrasonography measurements (aggregated sum of: su-
praspinatus tendon thickening (grade 0 to 3), fibrillar dis-
ruption (grade 0 to 3), calcification (grade 0 to 3) and
neovascularisation (grade 0 to 4) [33]).
The following secondary outcomes will only be mea-
sured at the 12-month follow-up assessment: number of
patients referred for, or completed, arthroscopic suba-
cromial decompression; patients given subacromial cor-
ticosteroid injections after the intervention period; the
number of visits to a general practitioner or secondary
healthcare setting due to the shoulder problem (registra-
tion in the Danish Central Office of Patient Registration);
and economic variables (for example, patient-reported
number of sick days from work and sport attributed to
the shoulder and time spent on rehabilitation in the
trial period and post-trial, (patient-reported and register-
controlled). Table 1 presents all outcome measures and at
which time point they will be collected.
Demographic data and other measurements will be
recorded, covering socio-economic variables such as:
employment, education, statement of income, history of
injury (for example, accident, slow development and fluc-
tuations), duration of current symptoms and physical de-
mands in work and/or hobby activities (patient-reported).
The patients will be instructed to complete an exercise
and pain diary. In the exercise diary, the patients will be
asked to report the number of sets and repetitions per
set for every training session, as well as the load during
the exercise. Self-reported pain will be registered imme-
diately before and 30 minutes after each training session.
All pain measurements will be reported on the Numeric
Pain Rating Scale. In addition to pain, patients will be
asked to report use of analgesics (type and amount).
Good compliance will be defined by attendance at four
out of the six visits to the physiotherapist, and an 80%
complete exercise diary, where 100% will be defined by
performance of 36 sessions of training (12 weeks at three
training sessions per week).
Data collection
Three outcome assessors will perform all enrolment,
baseline and follow-up assessments. Before starting the
data collection, the assessors will train together with the
primary investigator and decide on a consensus standard
of interpreting all outcome variables.
Sample size and power considerations
Studies on patients with SIS have shown mean baseline
values for DASH scores between 18 and 65, and stan-
dard deviations (SD) between 12 and 20 [30,31,43-47].
Often a 50% reduction in DASH score is seen after treat-
ment [30,31,44,46,47], and it is suggested that a 40%
change corresponds to a substantial improvement for
the patient [46]. Based on these data, we expect a mean
baseline of 40 points on the DASH questionnaire with
an SD of 17. We expect a 50% change (change from 40
to 20 DASH points) in the progressive high-load exer-
cise group, and 25% (change from 40 to 30 DASH
points) in the low-load exercise group (Figure 2A).
For a two-sample pooled t-test of a normal mean
difference with a two-sided significance level of 0.05
(P ≤0.05), assuming a common SD of 17 DASH points, a
sample size of 100 patients per group has a power of
0.985 (>95% power for the primary outcome) to detect a
between-group mean difference of 20 and 30 DASH
points after 12 weeks in the progressive high-load exer-
cise group and the low-load exercise group, respectively.
As the second objective is to explore the interaction
between corticosteroid use (yes or no) and exercise (pro-
gressive high-load exercise or low-load exercise), it is
hypothesised that, in the high-load group receiving corti-
costeroids at baseline, the DASH score at endpoint
(12 weeks) will be more favourable than those without
corticosteroids. With an SD of 17 DASH points, a
sample size of 62 patients per stratum (having pro-
gressive high-load exercise) will be required to obtain
a power of at least 0.9 (90%) to detect a mean differ-
ence of 10 DASH points between the two subgroups
within the progressive high-load exercise group (Figure
2B). Consequently, it is decided to include 260 pa-
tients in the study, assuming a similar number of
patients injected and not injected with corticosteroids
(1:1; 2 × 130 patients randomly assigned to each exer-
cise group (progressive high-load exercise versus low-
load exercise)).
A final deadline for patient recruitment is set at Marts
2015, meaning that patient recruitment stops when the
total number of 260 patients has been recruited, or the
deadline of Marts 2015 is reached. In case the target
number of 260 patients has not been met within the
specified recruitment period, the power of the study
will be less than expected. With an SD of 17 DASH
points, a sample size of 46 patients per group will be
required to obtain a power of at least 0.8 (80%) to
detect a mean difference of 10 DASH points between
the two groups.
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Table 1 Summary of measures to be collected
Article number Variable Baseline Week 3 Week 6 Week 9 Week 12 Week 52
Socio-demographic measurements
1, 2, 3 Age - year Yes n/a n/a n/a n/a n/a
1, 2, 3 Female sex – number (%) Yes n/a n/a n/a n/a n/a
1, 2, 3 Duration of symptoms - year Yes n/a n/a n/a n/a n/a
Symptom history
1, 2, 3 - Accident or acute incidence Yes n/a n/a n/a n/a n/a
1, 2, 3 - Slow consistent development (overload) Yes n/a n/a n/a n/a n/a
1, 2, 3 - Fluctuating development Yes n/a n/a n/a n/a n/a
Compliance with exercise protocol
1, 2, 3 - Visits to the physiotherapy department n/a n/a n/a n/a Yes n/a
1, 2, 3 - Exercise diary n/a n/a n/a n/a Yes n/a
1, 2, 3 - Pain diary n/a n/a n/a n/a Yes n/a
Patient reported and physiological measurements
1, 2, 3 Disabilities of the Arm, Shoulder and Hand (DASH)
questionnaire (range: 0 to 100) [36]
Yes Yes Yes Yes Yes Yes
1,2 Shoulder injury and Osteoarthritis Outcome Score (SOOS) [37] Yes n/a n/a n/a Yes Yes
1, 2 Hospital Anxiety and Depression Scale (HAD Scale,
range: 0 to 21) [38]
Yes n/a n/a n/a n/a n/a
1, 2 Visual analogue pain scale (VAS, range: 0 to 100) [40]
- Rest Yes n/a n/a n/a Yes n/a
- Maximum Yes n/a n/a n/a Yes n/a
- Activity Yes n/a n/a n/a Yes n/a
Isometric strength
1, 3 - Scaption Yes n/a n/a n/a Yes n/a
1, 3 - External rotation Yes n/a n/a n/a Yes n/a
1, 3 - Internal rotation Yes n/a n/a n/a Yes n/a
Degree of active movement
1, 3 - Scaption Yes n/a n/a n/a Yes n/a
1, 3 - External rotation Yes n/a n/a n/a Yes n/a
1, 3 - Internal rotation Yes n/a n/a n/a Yes n/a
Positive clinical test – number (%)
3 - SAT [41] Yes n/a n/a n/a Yes n/a
3 - SRT [42] Yes n/a n/a n/a Yes n/a
Ultrasonographic measurement [33]
1 - Hypoechoic scale (range: 0 to 3) Yes n/a n/a n/a Yes n/a
1 - Neovascularity scale (range: 0 to 4) Yes n/a n/a n/a Yes n/a
1 - Tendon swelling – mm Yes n/a n/a n/a Yes n/a
1 - Calcification (range: 0 to 3) Yes n/a n/a n/a Yes n/a
Socio-economic measurements
Referred to
1, 2 - Operation – number (%) n/a n/a n/a n/a Yes Yes
1, 2 - Corticosteroid injection(s) – number Yes n/a n/a n/a Yes Yes
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Randomisation and allocation concealment
Patients will be randomly assigned to either of the two
exercise groups with a 1:1 allocation as per a computer-
generated randomisation schedule, stratified by admi-
nistration of concomitant corticosteroid injection using
permuted blocks of random sizes (two to six). The pri-
mary investigator, assessors and administrator of the
randomisation procedure will not know block sizes in
order to ensure allocation concealment. In practice, after
recruitment and baseline measurements, the secretary at
the physiotherapy department will administer the allo-
cation procedure by taking a sequentially numbered,
opaque sealed envelope from one of two ring binders,
determined by the potential referral to corticosteroids
(yes or no) by the orthopaedic specialist.
Blinding
Outcome assessors will perform both baseline and follow-
up assessments, and will be kept blinded from treatment
allocation. At the follow-up assessments, patients will be
strongly encouraged not to disclose the components of
their exercise programme, in order to keep the outcome
assessor blinded. Patients will be blinded regarding exer-
cise allocation by informing them that the trial involves
testing two exercise programmes consisting of the same
exercises, and that they will be performed in two different
ways, but not defining the specific difference between
these, or which is hypothesised to be more effective.
Statistical analysis plan
The primary efficacy analysis performed is assessment of
the between-group difference in change in the DASH
score after 12 weeks in the intent-to-treat (ITT) popula-
tion (all randomised patients independent of compliance
and withdrawals). In the case of missing data due to drop-
outs, a non-responder imputation will be applied; a base-
line observation carried forward (BOCF) technique will be
used for patients who do not complete the study (as will
be illustrated in a corresponding trial flow diagram).
For the primary analyses at week 12, we will use
analysis of covariance (ANCOVA) to compare the
progressive high-load exercise group with the low-load
exercise group for mean changes from baseline in the
DASH score, as well as the secondary continuous out-
comes. The primary model includes the change from
baseline as the dependent variable, with treatment group
(progressive high-load exercise or low-load exercise),
corticosteroid status (yes or no), and the centre site
(one, two or three) as main effects, with the baseline
score as an additional covariate. The secondary analysis
for the primary outcome will add the interaction term
for group × corticosteroid in the primary model.
To analyse the longitudinal element of time effects of
DASH in the randomised trial (repeated measures de-
sign three, six, nine, and 12 weeks), a linear approach
will be used, fitted in SAS software (version 9.3 Service
Pack 4; SAS Institute Inc., Cary, North Carolina, United
States) using the procedure ‘PROC MIXED’ based on re-
stricted maximum likelihood (REML) estimates of the
parameters. The variable ‘patient’ will be applied as a
random effects factor. Assessment of the treatment and
time effects is of exploratory interest for the primary
outcome in testing for a possible interaction, and both
treatment and time will be used as systematic factors,
using the baseline value as covariate to reduce random
variation and increase power.
For all of the above analyses, results will be expressed
as the difference between the group means and 95%
confidence intervals with associated P values, based on
the mixed linear model. All data analyses will be carried
out according to the pre-established analysis plan, and
will be performed applying SAS software. All descriptive
statistics and tests will be reported in accordance with
the recommendations of the Enhancing the QUAlity and
Transparency Of health Research (EQUATOR) network
[48] and the Consolidating Standards of Reporting Trials
(CONSORT) statement [49]. In order to evaluate the
empirical distributions of the continuous outcomes, vis-
ual inspection (of the studentised residuals from the
statistical model) will be used to suggest whether the
assumption of normality and variance homogeneity is
reasonable.
Table 1 Summary of measures to be collected (Continued)
Shoulder related
2 - Visits to general practitioner – number n/a n/a n/a n/a Yes Yes
2 - Visits to secondary healthcare setting – number n/a n/a n/a n/a Yes Yes
2 - Sick days – number n/a n/a n/a n/a Yes Yes
2 Time spent on shoulder-related rehabilitation - hours n/a n/a n/a n/a Yes Yes
2 EuroQol-5D (EQ-5D, range: 0 to 100) [39] Yes n/a n/a n/a Yes Yes
n/a: not assessed; SAT: Scapulae Assistance Test; SRT: Scapulae Retraction Test.
Article 1: Progressive high-load exercise compared with general low-load exercise in patients with rotator cuff tendinopathy: a randomised trial.
Article 2: The effect of 12 weeks of progressive high-load exercise in patients with rotator cuff tendinopathy on patient-reported and economic outcomes –
12 months follow-up.
Article 3: The prognostic evaluation of clinical tests in patients with rotator cuff tendinopathy.
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Statistical analysis of the economic variables will be
presented as descriptive statistics, and a cost-utility ana-
lysis of the economic burden of each specific exercise
programme in relation to the EQ-5D will be performed,
expressed in quality-adjusted life years (QALYs) gained.
Interim analysis and early stopping rules
An early stopping rule will be applied when complete
rotator cuff ruptures, verified by ultrasonography, occur
due to the performance of the exercise programme. If
six or more cases of complete rupture occur in the pro-
gressive high-load exercise group, and the rate of rup-
ture is 50% more compared with the low-load exercise
group, the trial will be stopped.
Data monitoring
Since adverse events are expected to be minimal and the
intervention is not considered a high-risk intervention,
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Figure 2 Anticipated outcome (primary and secondary objectives). A: (Primary objective) Illustration of expected DASH score at 12 weeks.
Black = intervention group, White = control group. B: (Secondary objective) Illustration of expected DASH score at 12 weeks stratified for
concomitant corticosteroid injection. Columns I + II = intervention group, Columns III + IV = control group, Black = concomitant corticosteroid
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no data monitoring committee will be established. The
physiotherapists at each centre will be asked to report
adverse events to the primary investigator, who will re-
port these to the ethics committee and monitor if the
number of adverse events has reached the threshold for
the early stopping rule.
Ethics
All patients will participate on a voluntary basis and will be
informed that they can withdraw at any time without this
influencing their subsequent treatment. Informed consent
will be obtained from all patients. The Regional Scientific
Ethics Committee of Southern Denmark approved the trial
on the 27 June 2013 (project ID: S-20130071). The trial
was registered with the Danish Data Protection Agency
and approved on the 30 May 2013 (registration number:
2008-58-0035). The trial is registered at Clinicaltrials.gov
(identifier: NCT01984203). The Danish Act concerning
Processing of Personal Data (DAPPD) will be followed.
The trial will follow the principles of the Declaration of
Helsinki [50].
Discussion
The effect of exercise on the rehabilitation of SIS has
been well studied, but the latest systematic reviews
focusing on active exercise rehabilitation of SIS consist-
ently report that most studies are of low to moderate
quality [8,51-57]. This is primarily due to small sample
sizes, inadequate blinding of patients and/or investiga-
tors and incomplete intervention descriptions, making it
difficult to translate the results into clinical practice.
Furthermore, previous studies show a wide range in clin-
ical outcome (from some effect to almost no effect),
which is probably the result of mixed populations within
the SIS ‘umbrella of pathologies’, and variation in the
interventions used [8]. However, collectively there is evi-
dence that active exercise is effective in the rehabilitation
of SIS. When evaluating new treatment approaches that
already have some evidence of efficacy, it is considered
unethical to compare treatment with a placebo or simi-
lar. New approaches should at least always be tested
against current best practice.
The RoCTEx trial will add new knowledge to the field
as described in the following points. Firstly, the focus on
patients with rotator cuff tendinopathy will result in
a more homogeneous group, giving the possibility to
transfer exercise principles (such as progressive high-
load exercise) to the shoulder that previously have been
shown to have positive results in other body regions.
The specific exercises for this trial have been selected on
the basis of evidence from Electromyography (EMG)
studies, resulting in targeting primarily the m. supraspi-
natus, which is most often considered the site of tendi-
nopathy. In addition, the trial’s exercises will be focusing
on stabilising muscles for the scapulae, thereby provi-
ding the foundation for optimal functioning of the gle-
nohumeral joint [58-61]. Secondly, efforts will be made
to keep both primary assessors and patients blinded to
the intervention group, which has been one of the most
frequent criticisms of earlier studies. Thirdly, we will in-
clude an active rehabilitation strategy for our control
group in order to specify if the effect of the intervention
is due specifically to the high-load exercise, or merely to
the effect of improved muscle activation of the shoul-
der muscles. Fourthly, allowing for a subgroup of the
included patients having a corticosteroid injection if
deemed necessary by the orthopaedic specialist, and sub-
sequently stratifying for this effect, increases the external
validity of the results.
Since no gold standard exists for diagnosing rotator
cuff tendinopathy, the current inclusion criteria may be
questioned. The inherent diagnostic difficulties could re-
sult in the inclusion of patients not having rotator cuff
tendinopathy, thereby increasing participant variability
and thereby make it more difficult to reach a significant
result. However, our sample size is calculated on the
basis of studies with the same variation in populations,
thereby presumably taking this variation into account.
Furthermore, ultrasound has shown moderate sensitivity
and excellent specificity in diagnosing rotator cuff ten-
dinopathy. The excellent specificity of 0.88 suggests an
acceptable probability of not including patients who do
not have rotator cuff tendinopathy [62].
The multifactorial pathophysiology of SIS (rotator cuff
pathology and degeneration based on decreased vascu-
larity, scapular dyskinesia, instability of the glenohu-
meral joint or glenohumeral internal rotation deficit)
may result in patients not responding positively to a
single modality exercise programme. However, as we
focus our inclusion on those patients who have signs of
rotator cuff tendinopathy, and only distinguish the inter-
vention and control groups by the external load applied,
we expect that this will not excessively dilute the results.
Furthermore, the trial’s exercise programme will con-
sider the multifactorial origin by including exercises
focused on the overall strength, stability and mobility of
the scapula-humeral complex.
The progressive high-load exercise programme is opti-
mised in several ways that distinguish it from traditional
eccentric exercise programmes. The concentric heavy
slow resistance exercises are favourable because of their
similarity to daily activities, thereby presumably increa-
sing the likelihood of compliance. Furthermore, eccen-
tric exercises for the rotator cuff muscles may induce
a more unsuitable initial position, reducing the sub-
acromial space, with an anticipated increased risk of
subacromial impingement. Alternatively, using exercises
starting with a concentric phase, and allowing the
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patients only to do isometric exercises when restricted
by pain, will potentially minimise the risk of irritating
the subacromial structures.
The objective of the RoCTEx trial is to show whether
there is a significant advantage in progressive high-load
exercise compared with the more traditional low-load
exercise. If this is the case, the description and availa-
bility of a standardised progressive high-load exercise
programme will help practitioners to treat patients diag-
nosed with rotator cuff tendinopathy. If no difference
occurs between the two groups, practitioners will have
the possibility of allowing their patients to choose the
exercise modality that best optimises their compliance.
Trial status
At the time of submission of this study protocol, the trial
is ongoing and still recruiting patients. Recruitment began
November 2013, and is expected to end Marts 2015.
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